Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leukemia, Promyelocytic, Acute × tamibarotene × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Filgrastim 2 Cyclophosphamide 2 Busulfan 2 Arsenic Trioxide 2 tamibarotene 1 fludarabine phosphate 1 Tretinoin 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methotrexate 1 Idarubicin 1 Clofarabine 1 Bortezomib 1 Antilymphocyte Serum 1 AEG 35156 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00985530 2013-10-30

Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

Northwestern University

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡